Evidence map›Paper›PMID 34408563›Full record

ReviewPostepy dermatologii i alergologii2021

Medical infrared thermography as hidradenitis suppurativa diagnostic tool: literature review.

Erikas Mazeika, Vaiva Jariene, Skaidra Valiukeviciene

Open access · goldAbstract readReview
In one paragraph

Review in Postepy dermatologii i alergologii, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Erikas MazeikaDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno klinikos, Kaunas, Lithuania, European Reference Network for Rare and Complex Diseases of the Skin (ERN-Skin) member.
Vaiva JarieneDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno klinikos, Kaunas, Lithuania, European Reference Network for Rare and Complex Diseases of the Skin (ERN-Skin) member.
Skaidra ValiukevicieneDepartment of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno klinikos, Kaunas, Lithuania, European Reference Network for Rare and Complex Diseases of the Skin (ERN-Skin) member.
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a rare, chronic, inflammatory skin disease that has a strong impact on the quality of life. Medical infrared thermography (MIT) is a non-invasive imaging method that could be used for evaluation of skin inflammation, which is an important biomarker in HS. We performed a comprehensive review of the literature to verify the possibilities of using MIT for HS. Key words "hidradenitis suppurativa", "acne inversa" and "thermography" were used for PubMed, Embase and Scopus literature analysis and in total four articles fulfilled the inclusion criteria. The inflamed areas have shown the increase in temperature (34.3°C) and after the removal of lesions the temperature has become similar to the healthy skin sites. The margins of the inflammatory lesions identified by MIT were used in the surgical treatment. Also, MIT was used in combination with other imaging tests for inflammation evaluation. Thermography is an advantageous tool to detect inflammation and to secure the success of surgical treatment.

Indexed as

hidradenitis suppurativamedical infrared thermographysurgical treatment

Identifiers

PMID34408563
PMCPMC8362785
OpenAlexW3135478788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.